Literature DB >> 9923044

Increased serum C-reactive protein levels by immunonephelometry in patients with rapidly destructive hip osteoarthritis.

T Conrozier1, C Chappuis-Cellier, M Richard, P Mathieu, S Richard, E Vignon.   

Abstract

OBJECTIVE: To compare serum C-reactive protein levels measured using a highly sensitive immunonephelometry method in patients with rapidly destructive versus slowly progressive hip osteoarthritis.
METHODS: Ten patients meeting criteria for rapidly destructive hip osteoarthritis were compared to 25 patients with slowly progressive hip osteoarthritis defined as less than 0.20 mm joint space loss over the last year. Serum C-reactive protein was assayed using an immunonephelometry method with a detection threshold of 0.17 mg/L and a coefficient of variation of less than 5%.
RESULTS: One patient in each group was excluded because of a C-reactive protein level greater than 15 mg/L. The mean C-reactive protein level in the remaining 33 patients was 3.05 +/- 3.46 mg/L (range, 0.10-14.9 mg/L). Mean C-reactive protein was significantly higher in the rapidly destructive group than in the slowly progressive group (5.61 +/- 4.75 versus 1.94 +/- 1.98 mg/L, P = 0.01), even after adjustment for potential confounding factors.
CONCLUSION: Our data suggest that rapidly destructive hip osteoarthritis may be associated with some degree of inflammation reflected by a small but significant increase in serum C-reactive protein levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9923044

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  22 in total

Review 1.  Clinical assessment and significance of inflammation in knee osteoarthritis.

Authors:  V T Baddour; J D Bradley
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

2.  Ultrasound guided intra-articular ketorolac versus corticosteroid injection in osteoarthritis of the hip: a retrospective comparative study.

Authors:  Ki Deok Park; Tai Kon Kim; Byung Woo Bae; JaeKi Ahn; Woo Yong Lee; Yongbum Park
Journal:  Skeletal Radiol       Date:  2015-06-03       Impact factor: 2.199

3.  Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes.

Authors:  Jessica W Smith; Thomas B Martins; Evelyn Gopez; Troy Johnson; Harry R Hill; Thomas D Rosenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-10       Impact factor: 5.346

Review 4.  What is the utility of biomarkers for assessing the pathophysiology of hip osteoarthritis? A systematic review.

Authors:  Jeffrey J Nepple; Kayla M Thomason; Tonya W An; Marcie Harris-Hayes; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2015-05       Impact factor: 4.176

5.  Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.

Authors:  T Conrozier; M C Carlier; P Mathieu; F Colson; A L Debard; S Richard; H Favret; J Bienvenu; E Vignon
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

6.  Prospective associations of C-reactive protein (CRP) levels and CRP genetic risk scores with risk of total knee and hip replacement for osteoarthritis in a diverse cohort.

Authors:  A H Shadyab; R Terkeltaub; C Kooperberg; A Reiner; C B Eaton; R D Jackson; J L Krok-Schoen; R M Salem; A Z LaCroix
Journal:  Osteoarthritis Cartilage       Date:  2018-05-22       Impact factor: 6.576

7.  Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.

Authors:  P Garnero; T Conrozier; S Christgau; P Mathieu; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

8.  Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls.

Authors:  R Rollín; F Marco; J A Jover; J A García-Asenjo; L Rodríguez; L López-Durán; B Fernández-Gutiérrez
Journal:  Rheumatol Int       Date:  2008-01-18       Impact factor: 2.631

9.  Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein.

Authors:  T Stürmer; H Brenner; W Koenig; K-P Günther
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

10.  Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.

Authors:  V B Kraus; T V Stabler; G Luta; J B Renner; A D Dragomir; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2007-03-28       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.